SEC Form 4 · accession 0001209191-17-008613

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Jan 12, 2017

Accepted (ET)

Feb 8, 2017 · 2:25 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001400482

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jan 12, 2017	P	7,100	$63,447.32	A	8,259,556	I	By SBI Incubation Co., Ltd.
Common Stock^F3,F2	Jan 19, 2017	P	100	$869.60	A	8,259,656	I	By SBI Incubation Co., Ltd.
Common Stock^F4,F2	Jan 20, 2017	P	12,900	$111,884.33	A	8,272,556	I	By SBI Incubation Co., Ltd.
Common Stock^F5,F2	Jan 23, 2017	P	17,200	$150,643.21	A	8,289,756	I	By SBI Incubation Co., Ltd.
Common Stock	holding	—	—		—	6,196,869	D

No Table II lines on this filing.

F1The shares were purchased at a price of 7,310,400 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
F2These shares are held directly by SBI Incubation Co., Ltd., which is an indirect wholly-owned subsidiary of SBI Holdings, Inc. SBI Holdings, Inc. may be deemed to be the indirect beneficial owner of these securities.
F3The shares were purchased at a price of 99,900 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
F4The shares were purchased at a price of 12,884,600 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
F5The shares were purchased at a price of 17,167,300 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.